Chongqing Pharmaceutical Research Institute Co Ltd (CPRI) offers comprehensive generic API services ranging from initial development to commercialization, leveraging its expertise in non-infringing process innovation and cGMP manufacturing. The services encompass full-scale cGMP production of APIs and advanced intermediates, contract research for generic APIs and FDF, as well as contract manufacturing.
Products & Services
Abiraterone acetate non-sterile bulk drug substance
Amrinone
Canagliflozin
Canagliflozin monohydrate non-sterile bulk drug substance
Sites
Chongqing Pharmaceutical Research Institute
Country
People's Republic of ChinaAddress
Tu Shan Lu
Country
People's Republic of ChinaCity
Chongqing